-BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development,  announced an exclusive agreement* with KRISHGEN BioSystems, a leading provider of life science research tools and services for over two decades in India, Bangladesh and Nepal. KRISHGEN BioSystems’ long-standing experience and strong presence in the region, combined with BioIVT’s industry-leading products, will create unparalleled opportunities for researchers to access high-quality, reliable solutions.

Through this agreement, KRISHGEN BioSystems exclusively represents BioIVT’s comprehensive portfolio of biofluids, tissues, cell products, media, and subcellular fractions/enzymes in India, Bangladesh and Nepal. This diverse range of biological materials is essential for research in areas such as drug discovery, development, toxicology and personalized medicine. The commercial relationship will not only provide faster lead times and competitive pricing but also ensure ongoing technical support and customer service, further enhancing the overall research experience.

“We are excited to collaborate with KRISHGEN BioSystems and are confident that this commercial agreement will elevate life sciences research in India and beyond,” said Dimas Neto, Director, Global Channel Partnerships at BioIVT. “Together, we remain dedicated to advancing scientific discoveries that have the potential to transform healthcare and improve patient outcomes worldwide.”

“We are excited to deepen our partnership with BioIVT through this exclusive distribution agreement for India, Bangladesh and Nepal,” said Krisha Jain, VP, International Business Development at KRISHGEN BioSystems. “We believe that KRISHGEN BioSystems and BioIVT’s shared commitment to providing researchers with the highest quality biological materials has been a driving force behind our success.”